Skip to main content

SpyGlass Pharma, Inc.

SGP
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001778922

In the last 90 days, SpyGlass Pharma, Inc. insiders filed 1 open-market purchase and 0 sales; 69 institutions reported holding it in 13F filings for Q3 2026, worth $687.8M in total; no superinvestor holds it.

Holders of 5% or more of SGP

Holders whose latest Schedule 13D or 13G filing reports 5% or more of SpyGlass Pharma, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SGP
HolderLatest formStakeChangeFirst filedLatest filingFiling
Ra Capital Management, L.P.13D24.10%8.02M sharesNewFeb 17, 20261 filingFeb 17, 2026SEC
New Enterprise Associates 17, L.P.13D22.20%7.39M sharesNewFeb 13, 20261 filingFeb 13, 2026SEC
Vensana Capital I GP, LLC13D/A8.90%2.99M shares−1.00 ppfrom 9.90%Feb 10, 20262 filingsNov 18, 2026SEC
Sands Capital Life Sciences Pulse Fund III (DE), L.P.13G7.80%2.50M sharesNewFeb 13, 20261 filingFeb 13, 2026SEC
Gilde Healthcare Holding B.V.13D6.57%2.19M sharesNewFeb 13, 20261 filingFeb 13, 2026SEC
Samsara BioCapital, L.P.13G6.30%2.11M sharesNewFeb 17, 20261 filingFeb 17, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

7 Schedule 13D and 13G filings on SpyGlass Pharma, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SGP
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 18, 20264:47 PM ETVensana Capital I GP, LLCand 3 others13D/A8.90%2.99M shares−1.00 ppfrom 9.90%Nov 16, 2026SEC
Feb 17, 20267:23 PM ETSamsara BioCapital, L.P.and 4 others13G6.30%2.11M sharesNewFeb 9, 2026SEC
Feb 17, 20267:21 PM ETRa Capital Management, L.P.and 4 others13D24.10%8.02M sharesNewFeb 9, 2026SEC
Feb 13, 20266:21 PM ETNew Enterprise Associates 17, L.P.and 14 others13D22.20%7.39M sharesNewFeb 9, 2026SEC
Feb 13, 20264:05 PM ETGilde Healthcare Holding B.V.and 4 others13D6.57%2.19M sharesNewFeb 9, 2026SEC
Feb 13, 202611:36 AM ETSands Capital Life Sciences Pulse Fund III (DE), L.P.and 3 others13G7.80%2.50M sharesNewFeb 6, 2026SEC
Feb 10, 20266:29 PM ETVensana Capital I GP, LLCand 3 others13D9.90%3.31M sharesNewFeb 9, 2026SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell SpyGlass Pharma, Inc. shares, newest first.

Form 144 notices for SGP
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Nov 18, 20264:40 PM ETSamsara BioCapital, L.P.Shareholder37.2K$1.17MNov 18, 2026Merrill LynchSEC